Related Experiment Videos

Death the Fas way: regulation and pathophysiology of CD95 and its ligand

K Sharma1, R X Wang, L Y Zhang

  • 1Department of Immunology, Holland Laboratory, American Red Cross, 15601 Crabbs Branch Way, Rockville, MD 20855, USA.

Insights

Tumor necrosis factor receptor family members, like Fas/APO-1 and Fas ligand (FasL), regulate cell death. Their dysregulation is linked to aging, immune disorders, and cancer.

Area of Science:

  • Cellular Biology
  • Immunology
  • Molecular Biology

Background:

  • Apoptotic cell death is crucial for homeostasis, development, and disease.
  • The Fas/FasL pathway is a well-characterized death receptor system.
  • FasL binding to Fas triggers caspase cascades, leading to apoptosis.

Purpose of the Study:

  • To review the mechanisms regulating Fas and FasL expression.
  • To explore how Fas/FasL deregulation contributes to disease pathogenesis.

Main Methods:

  • Literature review of studies on Fas/FasL pathway.
  • Analysis of molecular mechanisms controlling Fas and FasL expression.
  • Examination of the role of Fas/FasL in various pathophysiological conditions.

Main Results:

  • Fas/FasL pathway mediates activation-induced cell death in the immune system.
  • Fas/FasL dysregulation is implicated in aging, HIV infection, drug abuse, stress, and cancer.
  • Caspase activation by Fas/FasL is a transcription-independent process.

Conclusions:

  • The Fas/FasL pathway is a critical regulator of cell death with broad implications in health and disease.
  • Understanding Fas/FasL regulation is key to developing therapeutic strategies for related disorders.

Related Concept Videos